Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in US

News
Article

The OTC eye drops contain low-dose brimonidine tartrate 0.025%.

Woman administering eye drops Image credit: AdobeStock/Katarina

LUMIFY Preservative Free is currently available in single-use vials at most US retailers nationwide. Image credit: AdobeStock/Katarina

Bausch + Lombhas launched its LUMIFY Preservative Free redness reliever eye drops in the US.1 The first and only preservation-free OTC eye drops contain low-dose brimonidine tartrate 0.025% that works to relieve redness of the eye due to minor eye irritations, according to a news release.

“Consumers often say how amazed they are at the difference our original LUMIFY makes to their eyes, with over 50,000 five-star reviews as proof,” said John Ferris, president, Consumer at Bausch + Lomb, in the release. “LUMIFY Preservative Free brings that same fast-acting formula to those with sensitive eyes — delivering a visibly brighter, whiter look in just 60 seconds.”

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that selectively target eye redness with a lower risk of rebound redness and loss of efficacy when used as directed, the release stated. The FDA approved LUMIFY Preservative Free eye drops in April 2024.1

“LUMIFY delivers consistently proven results for patients experiencing eye redness,” said Melissa Toyos, MD, partner of Toyos Clinic in Nashville, Tennessee, in the release. “With LUMIFY Preservative Free, my patients with eye sensitivities now have an option that’s just as effective as the original LUMIFY redness reliever eye drops.”

LUMIFY Preservative Free is currently available in single-use vials at most US retailers nationwide, including Walmart, Target, CVS, Walgreens, Rite Aid, and Amazon, among others. The drops have a manufacturer’s suggested retail price of $26.99 and will feature updated premium packaging.1

Reference:
  1. Bausch + Lomb launches new LUMIFY Preservative Free redness reliever eye drops in the United States. News release. Bausch + Lomb. May 21, 2025. Accessed May 21, 2025.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Brett Bielory, MD, at ASCRS 2025
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Dr Ben Gaddie chats about his dry eye presentation at SECO and ocular surface disease.jpg
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
© 2025 MJH Life Sciences

All rights reserved.